The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1350 a month. Under the ...
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...
This pocket-sized printer connects via Bluetooth to your phone and spits out credit-card-sized photos in minutes. Amazon has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback